Page 58 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

56
Chapter 3
References
1. Andreasen S, Therkildsen MH, Bjørndal K, Homøe P. Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck. 2016;38(Suppl.1):E1364-9. doi:10.1002/hed.24228
2. Valstar M, de Ridder M, van den Broek E, et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol. 2017;66:93-99. doi:10.1016/j.oraloncology.2017.01.004
3. Niparko JK, Beauchamp ML, Krause CJ, Baker SR, Work WP. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1986;112(11):1180- 1184.
4. Dawson AK. Radiation therapy in recurrent pleomorphic adenoma of the parotid. Int J Radiat Oncol Biol Phys. 1989;16(3):819-821.
5. Myssiorek D, Ruah C, Hybels R. Recurrent pleomorphic adenomas of the parotid gland. Head Neck. 1990;12(4):332-336.
6. Renehan A, Gleave EN, McGurk M. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am J Surg. 1996;172(6):710-714.
7. Fee WJ, Goffinet DR, Calcaterra TC, et al. Recurrent mixed tumors of the parotid gland-results of surgical therapy. Laryngoscope. 1978;88(2 Pt 1):265-273.
8. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006;66(4):1031-1035. doi:10.1016/j.ijrobp.2006.06.036
9. Jackson SR, Roland NJ, Clarke RW, Jones AS. Recurrent pleomorphic adenoma. J Laryngol Otol. 1993;107(6):546-549.
10. Phillips P, Olsen K. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature.tle. Ann Otol Rhinol Laryngol. 1995;104(2):447-452.
11. Yugueros P, Goellner JR, Petty PM, Woods JE. Treating recurrence of parotid benign pleomorphic adenomas. Ann Plast Surg. 1998;40(6):573-576.
12. Leverstein H, Tiwari R, Snow G, van der Wal J, van der Waal I. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland . Analysis and results in 40 patients. Eur Arch Otorhinolaryngol. 1997;254(7):313-317.
13. Wittekindt C, Streubel K, Arnold G, et al. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 2007 Sep;29(9)822-8. 2007;29(9):822-828. doi:10.1002/ hed.20613
14. Laskawi R, Schott T, Schroder M. Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg. 1998;36(1):48-51.
15. Glas AS, Vermey A, Hollema H, et al. Surgical treatment of recurrent plemorphic adenoma of the parotid gland: a clinical analysis of 52 patients. Head Neck. 2001;23(4):311-316.
16. Samson M, Metson R, Wang C, Montgomery W. Preservation of the facial nerve in the management of recurrent pleomorphic adenoma. Laryngoscope. 1991;101(10):1060-1062.
17. Makeieff M, Venail F, Cartier C, Garrel R, Crampette L, Guerrier B. Continuous facial nerve monitoring during pleomorphic adenoma recurrence surgery. Laryngoscope. 2005;115(7):1310-1314. doi:10.1097/01.MLG.0000166697.48868.8C
18. Maxwell EL, Hall FT, Freeman JL. Recurrent pleomorphic adenoma of the parotid gland. J Otolaryngol. 2004;33(3):181-184.
19. Makeieff M, Pelliccia P, Letois F, et al. Recurrent pleomorphic adenoma: results of surgical treatment. Ann Surg Oncol. 2010;17(12):3308-3313. doi:10.1245/s10434-010-1173-2.
20. Zbären P, Tschumi I, Nuyens M, Stauffer E. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg. 2005;189(2):203-207. doi:10.1016/j.amjsurg.2004.11.008
21. Redaelli de Zinis L, Piccioni M, Antonelli A, Nicolai P. Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol. 2008;265(4):447-452. doi:10.1007/s00405-007-0502-y